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I. Introduction
The recent increases in health care costs have led many to offer possible strategies for moderating the rate of growth. Ancillary services have been seen as a potentially productive target for cost containment strategies because some observers believe that a substantial portion of the utilization is unnecessary. Efforts directed toward achieving a more discerning use of ancillary services would also be consistent with an objective with which many clinicians would sympathize, a more reasoned practice of medicine.
The clinical laboratory is one aspect of ancillary services in which some cost containment strategies are being proposed and tested. In general, two different kinds of interventions have been discussed. The first set of strategies are regulatory in nature, and certificate of need control represents an example. Certificate of need is a requirement for public agency review and approval of planned expenditures by health care institutions in excess of a specified dollar amount.
Many states have already enacted certificate of need laws. In the clinical laboratory, these controls would potentially limit the technological capacity to perform tests. Those who espouse this kind of intervention believe that in limiting capacity, the availability of the technology will effectively be rationed, and those ordering tests will need to use clinical judgement to establish priorities for access to it. The hopeful result would be a decline in the volume of tests which are ordered.
An alternative set of strategies that have been or are being investigated in some clinical laboratories addresses directly the behavior of Proponents of the regulatory and behavioral approaches to contain costs in the clinical laboratory make the plausible assumption that, if a decrease in the volume of tests ordered can successfully be accomplished, a consequent decline in laboratory costs will be observed. It is of interest to be able to predict, however, the extent of the cost response to changes in test volume. A first inclination might be to determine if one would be justified in assuming that the variation is "elastic".
Were that to be the case, a hypothetical ten percent reduction in the number of laboratory tests ordered would lead to a similar ten percent decline in costs incurred. However, some refinement in the methodology will prove necessary. There will be a need to consider the fixed costs of a laboratory, which, to a first approximation, do not depend on the volume of tests performed. The problem is further complicated by the likelihood than any decrease in overall test volume would find the volumes of some tests, not necessarily the most costly ones, declining more than others. And, it would be an oversimplification, for reasons to be explained later, to use the rates at which most hospitals bill for laboratory tests to calculate cost savings that could result from declining utilization.
* It is extremely unlikey that a 10% reduction in utilization could lead to a savings of greater than 10% of costs. The theoretical possibility should, however, not be ignored.
In this paper, we describe and illustrate an approach to estimating the magnitude of cost-reduction or "cost behavior" that might be observed in response to hypothetical changes in the utilization of a clinical laboratory. We gained access to the chemistry laboratory records of a large metropolitan teaching hospital and we present the results of some preliminary calculations appropriate to that setting.
We approached the problem by first deriving the actual operating costs for the entire laboratory under study and for certain functional subdivisions of that laboratory. Once this task was completed, we attempted to estimate, for purposes of illustration, the cost savings to be realized if hypothetical 20% reduction in the number of tests ordered were effected by one of the cost-containment strategies described above. We report on how our estimates of the cost-savings changed with various refinements in the assumptions about the variability of laboratory costs and volumes. Finally, we comment on the need for recognizing limitations inherent in this highly preliminary analysis.
II. Methods
A. Characteristics of the Hospital and Chemistry Laboratory
The hospital whose chemistry laboratory we used to develop and illustrate our approach is major metropolitan teaching institution having more than 500 beds. In 1977, the year for which the most complete data was available for this analysis, the hospital served more than 20,000 in-patient admissions and well in excess of 300,000 out-patients visits.
In the same year, the magnitude of chemistry laboratory costs approached 1% of the total operating expenses of the hospital and chemistry revenues, a not much larger fraction of hospital revenue.
III
During 1977, the laboratory performed a total volume of nearly 1.3 million determinations distributed over the more than 100 different tests and procedures that were routinely offered.
The chemistry laboratory is organized into 10 rooms, each with a specialized function. Table 1 As can be seen from the information described above, the laboratory operation reflects the overall philosophy of the laboratory direction and the practitioners within the hospital that the ordering of individual chemistry tests is preferable to the use of multi-test panels. The hospital represented here is one of the busiest in the country and the demands made on laboratory under study were very great. Probably unlike other laboratories serving hospitals its size, the laboratory we studied had not, by 1977, followed the trend of introducing the highly automated analyzers.
We 
C. Costs
For our cost analysis, we needed to arrive at the "production function" for the chemistry laboratory as a whole and for the functionally specialized testing rooms. It would not have been valid to use laboratory test charges for the rates at which patients were billed for the tests performed. For this hospital and most others, the billing rate for laboratory tests, the so-called "charge," is paid only by patients without health insurance and by the commercial insurance carriers. State and federal hospital reimbursement programs and the Blue Cross agencies reimburse the hospitals in some proportion to actual costs which, in most instances, would be expected to be considerably lower than the billing rates. In order to determine the cost response to declining laboratory utilization, it is necessary to determine which categories described above are fixed and independent of volume and which others vary in relation to volume. In order to make this tentative determination, we aries can realistically be considered variable in the long run. Even though a year might or might not be quite enough time to achieve a staff reduction in this manner, salaries will be treated as variable in this analysis.
Because we assumed that the equipment configuration of the laboratory did not change during the year studied, equipment costs will be treated as fixed, at the replacement value of the instruments in use.
Service costs may in some instances be indirectly dependent on laboratory test volume. Under other circumstances it might have been a difficult decision as to whether to treat service costs as fixed or variable.
In this instance because they will be seen to represent a rather small percentage of total laboratory costs, we make the arbitrary decision to treat service costs as fixed. We were congnizant of the possibility that those tests contributing to the largest costs in the laboratory were not necessarily those being performed at the highest volume. In order to allow for the capability, in our analysis, of accounting for differences in rates of decline among individual tests to yield an overall twenty percent decline in laboratory test volume, if was necessary to consider the costs associated with performance of difference categories of tests. The categories of tests represented by the ten specialized laboratory workrooms represented a natural framework in which to consider costs at levels of aggregation beneath the whole laboratory. We determined the fixed and variable costs of performing tests in each of the functionally speicalized laboratory work rooms as well as in the laboratory as a whole. Personnel requirements used to calculate costs of operating the various work rooms were based on actual time studies conducted in the laboratory. These were compared to and found to be generally consistent with the standard work load reporting scheme used by the College of American Pathologists. The dollar value used for an average full time equivalent member of the technical staff was estimated to be $10,500 in 1977.
III. Discussion Table 3 reports for each functionally specialized room, the percent of the chemistry laboratory's total volume and cost accounted for in 1977 by that room. Note that the "Autoanalyzer" room and the "Electrolyte" room are the highest ranking in both their shares of laboratory test volumes and costs. But, other test groupings contributing significantly
to test volume make relatively less of a contribution to the total costs and vice versa. For example, tests conducted in the "Odd Jobs" room account for nearly 12% of total laboratory costs and just over 2% of the total volume. Note also that over 90% of the laboratory test volume is accounted for by the tests conducted in the 5 rooms performing the highest volume.
Next, we attempt to illustrate our approach by examining the cost behavior of declining utilization of the chemistry laboratory. A hypothetical 20% decline in utilization was assumed for the sake of discussion. This assumption would not be inconsistent with the magnitude of utilization decline observed and reported in the published literature as a result of educational and administrative interventions that were used in the studies.
By way of illustration, cost savings in response to decline in test volume utilization are estimated according to three scenarios, with each succeeding scenario representing a refinement over the previous case. The first scenario is our reference case in which we assume that all costs are variable with test volume in a elastic fashion. A 20% drop in utilization across the board will, therefore, result in a 20% decline in laboratory costs. Our a priori assumption is that this scenario is not realistic, however, it is included in order to serve as a reference against which the later scenarios can be compared. Using these assumptions and the costs of performing tests in the laboratory, a cost reduction of slightly more than $298,000 dollars would have been effected. This can also be expressed as an average saving of almost 28 full time equivalent technical personnel.* *For illustration, dollar savings are expressed as average FTE personnel. We do not mean to suggest that the laboratory could actually reduce its staffing level by 28 persons, even if this scenario were to hold true. In the third and final scenario we continue to assume that the average decline in the volume of laboratory tests performed is, as in the other cases 20%. However, we assume differential rates of decline among the range of tests offered in order to give this average value.
We treat the tests performed in the five highest volume laboratory work "rooms" as high volume tests and assume that their rate of decline is 21.5%, while low volume tests are assumed to show no decline at all.
The average volume decrease for the entire chemistry laboratory will still be approximately 20%. These high volume tests account for over 90% of the total laboratory's volume, but a lesser percent of total costs. In this scenario, the cost savings to result from the changing utilization would derive from the variable cost avoidance of the 21.5% decline in high-volume tests ordered. Using these assumptions and the costs of performing tests in the chemistry laboratory, the cost savings is even less than among observed in the earlier cases and amounts to only $182,000 dollars or about 17 full time equivalent technical staff members.
The results of this scenario analysis are summarized in Table 4 .
We have moved from the straightforward but highly unreaslistic scenario of overall elastic cost decline in response to volume decrease to scenarios that represent some degree of refinement in assumptions as to the treatment of fixed and variable costs and those which differentiate tests performed in high and low volume. Our illustrative calculations suggest that in the setting we chose to study, the magnitude of the dollar savings in response to test volume decline becomes progressively smaller as these factors are accounted for. We have certainly not been able to justifly or even identify all of the factors which would impact on the cost savings seen in response to a hypothetical decline in laboratory utilization. On the basis of the illustrative numbers presented above, it appears that the dollar savings associated with a hypothesized 20% decline in chemistry laboratory utilization would be at most 12.5% of dollar costs. Administrate staff of the hospital and laboratory in question have expressed their belief that any savings would, in fact, be considerably less than that.
The preliminary cost-behavior analysis described above is presented for the purpose of illustrating and discussing an approach that can potentially be used to estimate the efficacy of certain policy alternatives aimed at moderating health care costs through reductions in utilization.
___II_
This demonstration required the use of assumptions, which, in all instances are tentative and, in some cases, oversimplified. The irection of the demonstrated change in cost-savings when fixed cost and variable-volume factors are accounted for is probably worthy of some confidence; certaintly more than the actual numerical results of the scenario analyses presented for the laboratory we studied. Hence, it may be premature to consider the generalizability of either method or result to laboratories in other institutions having different size, organization, and operating philosophy. ----------------·--------- 
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